scispace - formally typeset
S

Spyros Deftereos

Researcher at National and Kapodistrian University of Athens

Publications -  48
Citations -  1727

Spyros Deftereos is an academic researcher from National and Kapodistrian University of Athens. The author has contributed to research in topics: Thalassemia & Heart failure. The author has an hindex of 18, co-authored 45 publications receiving 1303 citations.

Papers
More filters
Journal ArticleDOI

The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives.

TL;DR: In this article, the role of inflammation in both type 1 and type 2 diabetes (T1D and T1D) pathophysiology and associated metabolic disorders, has generated increasing interest in targeting inflammation to improve prevention and control of the disease.
Journal ArticleDOI

Literature mining, ontologies and information visualization for drug repurposing

TL;DR: This work reviews the application of literature mining and ontology modeling and traversal to the area of drug repurposing (DR), which has emerged as a noteworthy alternative to the traditional drug development process in response to the decreased productivity of the biopharmaceutical industry.
Journal ArticleDOI

Thalassemia Heart Disease: A Comparative Evaluation of Thalassemia Major and Thalassemia Intermedia

TL;DR: Regular lifelong transfusion and chelation therapy in TM prevented premature heart disease and pulmonary hypertension, although LV dysfunction still occurred and led to heart failure.
Journal ArticleDOI

Drug repurposing and adverse event prediction using high‐throughput literature analysis

TL;DR: This review will focus on those approaches to drug repurposing and adverse event prediction that are based on the biomedical literature that begin with an analysis of the literature and aim to reveal indirect relationships among seemingly unconnected biomedical entities.
Journal ArticleDOI

Hypothyroidism is a Risk Factor for New-Onset Diabetes: A Cohort Study.

TL;DR: Hypothyroidism is a risk factor for diabetes mellitus and subclinical hypothyroidistan-associated risk for DM is prominent only upon statin use, and identifying and treating hypothy thyroid hormone replacement therapy might reduce DM risk.